Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis



Armstrong, Rachael E, Frith, Lucy ORCID: 0000-0002-8506-0699, Ulph, Fiona M and Southern, Kevin W ORCID: 0000-0001-6516-9083
(2020) Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis. International Journal of Neonatal Screening, 6 (2). 40 - 40.

WarningThere is a more recent version of this item available.
[img] Text
Southern et al final.docx - Author Accepted Manuscript

Download (1MB)

Abstract

Newborn bloodspot screening for cystic fibrosis is a valid public health strategy for populations with a high incidence of this inherited condition. There are a wide variety of approaches to screening and in this paper, we propose that a bioethical framework is required to determine the most appropriate screening protocol for a population. This framework depends on the detailed evaluation of the ethical consequences of all screening outcomes and placing these in the context of the genetic profile of the population screened, the geography of the region and the healthcare resources available. View Full-Text

Item Type: Article
Uncontrolled Keywords: cystic fibrosis, newborn bloodspot screening, cystic fibrosis screen positive, inconclusive diagnosis (CFSPID), bioethics
Depositing User: Symplectic Admin
Date Deposited: 15 Jul 2020 10:24
Last Modified: 18 Jan 2023 23:40
DOI: 10.3390/ijns6020040
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3094107

Available Versions of this Item